Gastric cancer (stomach cancer) is the second most common type of cancer in the world. Most cancers of the stomach arise in the antrum,which is the lower third of the stomach,near the duodenum. There are different kinds of stomach cancers, depending on the type of cells from which the cancer arises. Cancers that form in the stomach’s secretory glands are called adenocarcinomas; these are the most common form, accounting for more than 90 percent of all stomach cancers. Other types are sarcomas (cancers of the stomach’s muscle layer), and gastric lymphomas, which form in certain immune cells (B and T cells) of the stomach tissue. Adenocarcinoma of the stomach is strongly associated with H.pylori infection.Recent studies of patients with stomach cancer have revealed that over 90 percent of people who develop adenocarcinoma of the stomach have H. pylori infections. So, what is it about H. pylori that predisposes certain people to develop cancer? A recent theory on the development of stomach cancer revolves around the interaction between the H. pylori organism itself and the infected person’s own immune response.
H. Pylori And Gastric Cancer
The role of H. pylori in the development of stomach cancer fits the multi-stage theory of carcinogenesis very well. There are two important factors in the formation of gastric cancer,and it is likely that they act in a cooperative manner to produce the cancerous changes. First,the host’s own immune system,which releases bacteria killing products as it battles infection,causes damage to the DNA of the stomach lining’s cells (initiation). Second, the bacterium itself and the products that it makes may directly injure or kill the cells lining the stomach, leading to an increased turnover rate of cells in the tissue (promotion), a decreased rate of cell death (apoptosis),and a change in gene expression that leads to a shift away from normal stomach cell functioning.
The strain of H. pylori to which a person is exposed may influence the risk of developing gastric cancer. Strains of H. pylori that produce high levels of two proteins, vacuolating toxin A (VacA) and the cytotoxin-associated gene A (CagA), appear to cause greater tissue damage than those that produce lower levels,or that lack those genes completely.These proteins are directly toxic to cells lining the stomach and signal strongly to the immune system that an invasion is underway.As a result of the bacterial presence, neutrophils and macrophages set up residence in the tissue to fight the bacteria assault.
Macrophages and neutrophils produce a number of substances that are destructive to neighboring cells, and that may, in fact, lead to mutations in the DNA of tissue cells. One of these substances is nitric oxide (NO), an antibacterial product that is made by neutrophils and dumped into the surrounding area to cleanse the region of invading microbes. NO, however, is a powerful oxidizing agent (similar to hydrogen peroxide); the activity of these strong oxidants causes small breaks in the DNA of the cells immediately surrounding the neutrophil.
These breaks can lead to a loss of genes (such as tumor suppressors), a rearrangement of genes, or to other genetic mutations that change how the protein functions (including, for example, permanent activation of oncogenes, which promote cell growth, or inactivation of genes that stop cell growth). Indeed, a number of gastric cancers have been observed to cause a loss of the tumor suppressor function, an activation of oncogenes,and changes in many other genes that regulate the rate of cell growth and apoptosis. These changes in DNA and gene expression are also reflected in the re-organization of cells in the tissues a re-organization that can be seen through a microscope.The destruction of cells in the stomach tissue results in a condition known as gastric atrophy.Gastric atrophy can then progress to another state known as intestinal metaplasia,in which epithelial cells lining the stomach take on different characteristics, and thus the organization of the tissue becomes more like that of the intestine than the stomach. The stomach tissue’s loss of function that stems from this re-organization is believed to be an early indicator that all is not well in that region. The risk of gastric cancer increases rapidly as the degree of inflammation and metaplasia increases.
As metaplasia worsens, the tissue takes on a more disorganized appearance and function. So now, instead of behaving like intestinal cells,the cells become more disordered and eventually reach a state called dysplasia, a more dangerous condition in which the cells ignore most of the rules that govern cell growth and function (Figure 7.3). The result is a chaotic state of excess growth, invasion, and spread. This is thought to be the last step before the tissue becomes truly cancerous. The transition from metaplasia to cancer may involve additional genetic rearrangements,including loss of more tumor suppressors and activation of more oncogenes.
Eventually,the dysplastic tissue may become cancerous,or malignant. Malignant cells may then gain the ability to move out of their immediate vicinity to more distant sites. They do this by entering the circulatory or lymph systems, by which they are carried to other organs, such as the liver or pancreas. This process is known as metastasis. There, the cells form metastatic colonies that hijack the function of the organ to which they have spread. So, for example, if the gastric adenocarcinoma metastasizes to the liver,cancer cells replace normal liver cells in the region of the liver where the cancer is growing. That area then ceases to function like liver tissue and begins to function like the cancer tissue that has replaced it.
This is a very serious stage in the life cycle of the disease, a stage at which medical treatment becomes more difficult. As with most cancers, early intervention improves the outcome. Early diagnosis and medical treatment are very important in helping a person to recover from gastric cancer.
Stomach Cancer Stages & diagnosis
Early diagnosis can be achieved if early warning signals such as bleeding are caught. If you are over fifty, an annual fecal blood test can discover any internal bleeding. If a colonoscopy then proves negative, an upper endoscopic investigation should be done. Most of this bleeding will be caused by gastritis or an ulcer, but it also may be caused by cancer. Once cancer is identified, it is staged by scanning the body with CT or ultrasound. This will guide treatment and determine if cancer has spread, and if so,where. Staging cannot be complete until after surgery,
when nearby lymph nodes and organs can be tested.
The 1997 American Joint Committee on Cancer issued a Stomach Cancer Stages manual that presents the TNM classification system for staging gastric cancer:
Stomach Cancer Stages
TX = primary tumor (T) cannot be assessed
TO = no evidence of primary tumor
Tis = carcinoma in situ
T1 = tumor invading the submucosa
T2 = tumor invading the stomach wall muscle
T3 = tumor has penetrated the wall without invading adjacent
T4 = tumor has invaded adjacent structures
There are additional staging labels for regional and distant metastases, as well as ways to chart the pattern of spread.
Stomach Cancer Symptoms
It is hard to find stomach cancer in its early stage because there often are no symptoms. When the symptoms do occur, they can be vague, and people often ignore them. Stomach Cancer Symptoms usually arrive late because of the large capacity of the stomach. Anyone who feels full after eating a small amount should have an upper gastrointestinal endoscopy to rule out cancer.
Stomach Cancer Symptoms include:
• indigestion or a burning sensation like heartburn
• discomfort or pain in the abdomen
• nausea and vomiting
• diarrhea or constipation
• bloating of the stomach after meals
• loss of appetite
• weakness and fatigue
• vomiting blood or passing blood in the stool
These symptoms also are typical of any number of other gastrointestinal conditions, so they all need to be ruled out.
Learn How to Cure H Pylori Infection Naturally